Intravenous lipid and bilirubin-albumin binding variables in premature infants.
BACKGROUND
The lipid intake at which a significant bilirubin-displacing effect occurs as a function of gestational age (GA) is unclear.


OBJECTIVE
To determine the effect of gradual increase in IL intake from 1.5 to 3 g/kg per day on bilirubin-albumin binding variables as a function of GA in premature infants with indirect hyperbilirubinemia.


METHODS
Infants of 24 to 33 weeks' gestation at birth who received IL (20% Intralipid [Fresenius Kabi, Uppsala, Sweden]) doses of 1.5, 2, 2.5, and 3 g/kg per day over 4 consecutive days were prospectively evaluated. The blood samples were drawn twice at least 8 hours apart on each IL intake to measure total serum bilirubin and free bilirubin by the peroxidase test. The highest free bilirubin on each IL intake, the corresponding total serum bilirubin, and serum albumin were used to calculate the bilirubin/albumin binding constant or binding affinity.


RESULTS
Sixty-two infants (median GA: 28 weeks) were studied during the first 10 days of life. None of the subjects had culture-proven sepsis, had triglyceride levels of >2.05 mmol/L, or were receiving steroids. Infants were grouped in 2-week GA intervals. The cumulative frequency of elevated free bilirubin concentration (>or=90th percentile or B(f) >or= 32 nmol/L) as a function of IL intake was inversely related to GA and was significantly different among 2-week GA groups. There was significant decrease in binding affinity and increase in free bilirubin concentration with higher IL intake for <or=28 week but not for >28 week GA groups.


CONCLUSIONS
The IL intake may be associated with a significant fall in the binding affinity of bilirubin for plasma protein and a concomitant increase in free bilirubin concentration in premature infants. The lipid intake at which this occurs depends on GA.
Amin
Sanjiv B
SB
Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, Rochester, New York 14642, USA. sanjiv_amin@urmc.rochester.edu
Harte
Theresa
T
Scholer
Lori
L
Wang
Hongyue
H
D001663:Bilirubin / Q000097:blood*; D005217:Fat Emulsions, Intravenous; D005865:Gestational Age; D006801:Humans; D051556:Hyperbilirubinemia, Neonatal / Q000097:blood* / Q000628:therapy*; D007231:Infant, Newborn; D007234:Infant, Premature; D011446:Prospective Studies
D005217:Fat Emulsions, Intravenous; D001663:Bilirubin